Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1.04
LTS:0QQD's Cash to Debt is ranked higher than
64% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. LTS:0QQD: 1.04 )
LTS:0QQD' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 1.04

Equity to Asset 0.68
LTS:0QQD's Equity to Asset is ranked higher than
74% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. LTS:0QQD: 0.68 )
LTS:0QQD' s 10-Year Equity to Asset Range
Min: 0.03   Max: 0.84
Current: 0.68

0.03
0.84
Interest Coverage 14.77
LTS:0QQD's Interest Coverage is ranked higher than
56% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. LTS:0QQD: 14.77 )
LTS:0QQD' s 10-Year Interest Coverage Range
Min: 14.37   Max: 9999.99
Current: 14.77

14.37
9999.99
F-Score: 7
Z-Score: 6.18
M-Score: -2.54
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 23.96
LTS:0QQD's Operating margin (%) is ranked higher than
96% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. LTS:0QQD: 23.96 )
LTS:0QQD' s 10-Year Operating margin (%) Range
Min: 21.07   Max: 33.34
Current: 23.96

21.07
33.34
Net-margin (%) 17.04
LTS:0QQD's Net-margin (%) is ranked higher than
93% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. LTS:0QQD: 17.04 )
LTS:0QQD' s 10-Year Net-margin (%) Range
Min: 12.71   Max: 23.87
Current: 17.04

12.71
23.87
ROE (%) 12.63
LTS:0QQD's ROE (%) is ranked higher than
87% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. LTS:0QQD: 12.63 )
LTS:0QQD' s 10-Year ROE (%) Range
Min: 10.46   Max: 115.87
Current: 12.63

10.46
115.87
ROA (%) 8.39
LTS:0QQD's ROA (%) is ranked higher than
88% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. LTS:0QQD: 8.39 )
LTS:0QQD' s 10-Year ROA (%) Range
Min: 7.56   Max: 32.15
Current: 8.39

7.56
32.15
ROC (Joel Greenblatt) (%) 40.16
LTS:0QQD's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. LTS:0QQD: 40.16 )
LTS:0QQD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 35.96   Max: 119.58
Current: 40.16

35.96
119.58
Revenue Growth (3Y)(%) 8.60
LTS:0QQD's Revenue Growth (3Y)(%) is ranked higher than
82% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. LTS:0QQD: 8.60 )
LTS:0QQD' s 10-Year Revenue Growth (3Y)(%) Range
Min: 8.6   Max: 25.6
Current: 8.6

8.6
25.6
EBITDA Growth (3Y)(%) 9.40
LTS:0QQD's EBITDA Growth (3Y)(%) is ranked higher than
83% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. LTS:0QQD: 9.40 )
LTS:0QQD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 3.1   Max: 39.6
Current: 9.4

3.1
39.6
EPS Growth (3Y)(%) 14.30
LTS:0QQD's EPS Growth (3Y)(%) is ranked higher than
85% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. LTS:0QQD: 14.30 )
LTS:0QQD' s 10-Year EPS Growth (3Y)(%) Range
Min: -3.1   Max: 41.7
Current: 14.3

-3.1
41.7
» LTS:0QQD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

Latest Guru Trades with LTS:0QQD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.80
0QQD's P/E(ttm) is ranked higher than
88% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 84.60 vs. 0QQD: 24.80 )
0QQD' s 10-Year P/E(ttm) Range
Min: 9.08   Max: 61.06
Current: 24.8

9.08
61.06
P/B 2.97
0QQD's P/B is ranked higher than
76% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. 0QQD: 2.97 )
0QQD' s 10-Year P/B Range
Min: 1.31   Max: 6.26
Current: 2.97

1.31
6.26
P/S 4.21
0QQD's P/S is ranked higher than
66% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. 0QQD: 4.21 )
0QQD' s 10-Year P/S Range
Min: 1.82   Max: 8.95
Current: 4.21

1.82
8.95
PFCF 28.73
0QQD's PFCF is ranked higher than
88% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 28.73 )
0QQD' s 10-Year PFCF Range
Min: 9.54   Max: 50.48
Current: 28.73

9.54
50.48
EV-to-EBIT 17.25
0QQD's EV-to-EBIT is ranked higher than
90% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. 0QQD: 17.25 )
0QQD' s 10-Year EV-to-EBIT Range
Min: 6.8   Max: 45.8
Current: 17.25

6.8
45.8
PEG 3.02
0QQD's PEG is ranked higher than
93% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 3.02 )
0QQD' s 10-Year PEG Range
Min: 0.42   Max: 5.43
Current: 3.02

0.42
5.43
Shiller P/E 28.69
0QQD's Shiller P/E is ranked higher than
92% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 28.69 )
0QQD' s 10-Year Shiller P/E Range
Min: 10.71   Max: 39.22
Current: 28.69

10.71
39.22
Current Ratio 3.96
0QQD's Current Ratio is ranked higher than
80% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. 0QQD: 3.96 )
0QQD' s 10-Year Current Ratio Range
Min: 1.14   Max: 5.09
Current: 3.96

1.14
5.09
Quick Ratio 2.89
0QQD's Quick Ratio is ranked higher than
79% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. 0QQD: 2.89 )
0QQD' s 10-Year Quick Ratio Range
Min: 0.71   Max: 3.69
Current: 2.89

0.71
3.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.56
0QQD's Dividend Yield is ranked lower than
75% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 1.35 vs. 0QQD: 0.56 )
0QQD' s 10-Year Dividend Yield Range
Min: 0.28   Max: 1.1
Current: 0.56

0.28
1.1
Dividend Payout 0.14
0QQD's Dividend Payout is ranked higher than
97% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 0.14 )
0QQD' s 10-Year Dividend Payout Range
Min: 0.15   Max: 0.23
Current: 0.14

0.15
0.23
Yield on cost (5-Year) 0.56
0QQD's Yield on cost (5-Year) is ranked lower than
71% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. 0QQD: 0.56 )
0QQD' s 10-Year Yield on cost (5-Year) Range
Min: 0.28   Max: 1.1
Current: 0.56

0.28
1.1
Share Buyback Rate 5.10
0QQD's Share Buyback Rate is ranked higher than
97% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. 0QQD: 5.10 )
0QQD' s 10-Year Share Buyback Rate Range
Min: 6.6   Max: -8.4
Current: 5.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.74
0QQD's Price/Tangible Book is ranked higher than
72% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. 0QQD: 5.74 )
0QQD' s 10-Year Price/Tangible Book Range
Min: 4.19   Max: 233.33
Current: 5.74

4.19
233.33
Price/DCF (Projected) 1.37
0QQD's Price/DCF (Projected) is ranked higher than
93% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 1.37 )
0QQD' s 10-Year Price/DCF (Projected) Range
Min: 0.58   Max: 2.12
Current: 1.37

0.58
2.12
Price/Median PS Value 1.18
0QQD's Price/Median PS Value is ranked higher than
72% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. 0QQD: 1.18 )
0QQD' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 2.63
Current: 1.18

0.57
2.63
Price/Peter Lynch Fair Value 3.36
0QQD's Price/Peter Lynch Fair Value is ranked higher than
95% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 3.36 )
0QQD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.66   Max: 3.1
Current: 3.36

0.66
3.1
Price/Graham Number 2.49
0QQD's Price/Graham Number is ranked higher than
85% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 2.49 )
0QQD' s 10-Year Price/Graham Number Range
Min: 1.36   Max: 22.07
Current: 2.49

1.36
22.07
Earnings Yield (Greenblatt) 5.80
0QQD's Earnings Yield (Greenblatt) is ranked higher than
89% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. 0QQD: 5.80 )
0QQD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.2   Max: 14.7
Current: 5.8

2.2
14.7
Forward Rate of Return (Yacktman) 11.26
0QQD's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.52 vs. 0QQD: 11.26 )
0QQD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9   Max: 45.7
Current: 11.26

9
45.7

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:ZMH.Switzerland, ZMH.USA, ZIM.Germany,
Zimmer Holdings Inc was incorporated in 2001. The Company designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provides other healthcare related services. Its products include orthopaedic reconstructive implants, spinal and trauma devices, biologics, dental implants and related surgical products. Its orthopaedic reconstructive devices restore function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Its dental reconstructive implants restore function and aesthetics in patients who have lost teeth due to trauma or disease. Its spinal devices are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. Its trauma products are devices used to reattach or stabilize damaged bone and tissue to support the body's natural healing process. The Company has its operations in more than 25 countries and markets its products in more than 100 countries. The Company operates in a single industry but have three reportable geographic segments, the Americas, Europe and Asia Pacific. The Americas, which is comprised of the U.S. and includes other North, Central and South American markets; Europe, which is comprised of Europe and includes the Middle East and African markets; and Asia Pacific, which is comprised of Japan and includes other Asian and Pacific markets. The Company's customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. It markets and sells its products through three channels; direct to healthcare institutions, such as hospitals, referred to as direct channel accounts; through stocking distributors and healthcare dealers; and directly to dental practices and dental laboratories. The Company operates distribution facilities domestically in Warsaw, Indiana; Southaven, Mississippi; and Carlsbad, California and internationally in Australia, Austria, Belgium, Canada, the Czech Republic, China, Finland, France, Germany, Hong Kong, India, Italy, Japan, Korea, Malaysia, the Netherlands, New Zealand, Portugal, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand and the United Kingdom. The Company competes with the DePuy Synthes Companies of Johnson & Johnson, Stryker Corporation, Biomet, Inc., and Smith & Nephew plc. It protects its proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with vendors, employees, consultants and others who may have access to proprietary information. The Company is subject to government regulation in the countries in which it conducts business.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK